Pyrexia, commonly known as fever, is a frequently encountered symptom in clinical practice. It is a physiological response to various conditions, primarily infections, but also non-infectious diseases and drug reactions. Understanding the underlying mechanisms and management strategies is crucial for effective patient care.
The hypothalamus, acting as the body's thermostat, plays a pivotal role in fever development. Pyrogens, substances that induce fever, can be either exogenous, such as microbial toxins, or endogenous, like cytokines. These pyrogens trigger the synthesis of prostaglandin E2 (PGE2) in the hypothalamus, raising the body's set point temperature.
Initial assessment should focus on identifying the cause of the fever. History taking and physical examination are essential. Particular attention should be paid to recent travel, exposure to infectious diseases, drug history, and the presence of localizing symptoms. Investigations may include blood tests, imaging, and cultures depending on the clinical picture.
Management is generally twofold: treating the underlying cause and managing the fever itself. Antipyretics, such as paracetamol and nonsteroidal anti-inflammatory drugs (NSAIDs), can be used to reduce discomfort. However, it is important to remember that fever is a beneficial response that aids in pathogen clearance. Thus, antipyretics should not be used routinely without a clear indication.
Special populations such as infants, elderly, and immunocompromised individuals may present atypically or have a greater risk of serious underlying conditions. Therefore, a high degree of suspicion is warranted in these cases.
Pyrexia is a common but complex clinical presentation. A thorough understanding of its pathophysiology, clinical assessment, and management strategies is essential for healthcare professionals. While fever often indicates an underlying infectious process, it is crucial to consider non-infectious etiologies and tailor the management approach accordingly.
1.
FDA Declines to Approve Achieve Life Sciences' Smoking-cessation Drug
2.
Uncovered biology underlies a novel drug used to treat triple-negative breast cancer.
3.
Chemotherapy damage to non-cancer cells may be the cause of breast cancer recurrence.
4.
Never in a million years did I think I'd have to limit my chemotherapy.
5.
Treating Depression: Crucial for Recovery From Fibromyalgia
1.
HCC in Melanoma: Role of HCC Codes and Moderate Whole Body Hyperthermia
2.
Clinical Analysis of Prostate Cancer
3.
Sorafenib: Understanding the science behind a powerful cancer drug
4.
Early-Onset GI Cancers: Screening, AI Innovations & Research Advances 2025
5.
Comprehensive Breakthroughs in Oncology for Better Care
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Understanding the Evolution in Lung Cancer- An Initiative from Manipal Hospitals: Further Discussion
2.
Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL
3.
A Continuation to Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer
4.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
5.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation